Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report

Yeong Yeh Lee, Vincent Tee

Abstract

Non-alcoholic fatty liver disease is one of the main causes of elevated liver enzymes and chronic liver disease worldwide. It ranges from steatosis to steatohepatitis, leading to cirrhosis and related liver dysfunction. Silymarin is a herbal medicine, mostly used for liver disorders owing to its supposed hepatoprotective action. This report recommends silymarin in a patient with diabetes and grade II non-alcoholic steatohepatitis, confirming significant hepatoprotective effects as shown by the reduction of liver enzyme activities.

This article is part of the Current clinical use of silymarin in the treatment of toxic liver diseases: a case series Special Issue: https://dic-wp.zaphod.dev/special_issues/current-clinical-use-of-silymarin-in-the-treatment-of-toxic-liver-diseases-a-case-series

Article Details

Article Type

Case Report

DOI

10.7573/dic.2023-2-10

Categories

Publication Dates

Accepted: ; Published: .

Citation

Lee YY, Tee V. Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report. Drugs Context. 2023;12:2023-2-10. https://doi.org/10.7573/dic.2023-2-10

Article Views

Monthly article views (last 11 months)

Drugs in Context PubMed Central
Source HTML views PDF downloads Totals
Drugs in Context since September 15, 2025 5 1 6
PubMed Central since November 1, 2024 63 0 63
Totals 68 1 68
Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.